Correction: Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies.
作者信息
Ma Wangbin, Shi Qiao, Zhang Lilong, Qiu Zhendong, Kuang Tianrui, Zhao Kailiang, Wang Weixing
机构信息
Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Hubei Key Laboratory of Digestive System Disease, Wuhan, China.
出版信息
BMC Cancer. 2024 Jul 16;24(1):844. doi: 10.1186/s12885-024-12638-3.
Abstract
摘要
相似文献
1
Correction: Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies.
BMC Cancer. 2024 Jul 16;24(1):844. doi: 10.1186/s12885-024-12638-3.
2
Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies.
BMC Cancer. 2024 Jul 11;24(1):830. doi: 10.1186/s12885-024-12579-x.
3
Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Ann Transl Med. 2019 Oct;7(20):531. doi: 10.21037/atm.2019.09.160.
4
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Oncologist. 2021 Dec;26(12):1017-1025. doi: 10.1002/onco.13922. Epub 2021 Aug 18.
5
Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations.
Cancer Manag Res. 2021 Feb 24;13:1719-1731. doi: 10.2147/CMAR.S288337. eCollection 2021.
6
Unraveling the obesity paradox in small cell lung cancer immunotherapy: unveiling prognostic insights through body composition analysis.
Front Immunol. 2024 Aug 26;15:1439877. doi: 10.3389/fimmu.2024.1439877. eCollection 2024.
7
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Markers for Advanced Non-Small-Cell Lung Cancer Treated with Immunotherapy: A Systematic Review and Meta-Analysis.
Medicina (Kaunas). 2022 Aug 8;58(8):1069. doi: 10.3390/medicina58081069.
8
[Combining radiotherapy with immunotherapy for urological malignancies].
Urologe A. 2018 Nov;57(11):1309-1315. doi: 10.1007/s00120-018-0789-x.
9
Immunotherapy with radiotherapy in urological malignancies.
Curr Opin Urol. 2016 Nov;26(6):514-22. doi: 10.1097/MOU.0000000000000335.
10
Pattern of urological malignancies seen at Federal Medical Centre Gombe North Eastern Nigeria.
Niger J Med. 2012 Apr-Jun;21(2):237-40.
引用本文的文献
1
The Impact of Body Composition on Outcomes in NSCLC Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review.
Cancers (Basel). 2025 Aug 25;17(17):2765. doi: 10.3390/cancers17172765.
本文引用的文献
1
Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies.
BMC Cancer. 2024 Jul 11;24(1):830. doi: 10.1186/s12885-024-12579-x.
Zotero 插件